Qingdao Haiyingkang Investment Co., Ltd. and INKON Life Technology Co., Ltd. completed the acquisition of Shenzhen Shengzhong Investment Enterprise (Limited Partnership) from a group of shareholders.
November 13, 2022
Share
Qingdao Haiyingkang Investment Co., Ltd. and INKON Life Technology Co., Ltd. (SZSE:300143) agreed to acquire Shenzhen Shengzhong Investment Enterprise (Limited Partnership) from a group of shareholders for CNY 87.7 million on October 25, 2022. The transaction is approved by board of directors of INKON Life Technology Co., Ltd.
Qingdao Haiyingkang Investment Co., Ltd. and INKON Life Technology Co., Ltd. (SZSE:300143) completed the acquisition of Shenzhen Shengzhong Investment Enterprise (Limited Partnership) from a group of shareholders on November 14, 2022.
INKON Life Technology Co., Ltd., formerly Starmap medicine & technology Co., Ltd., is a China-based company principally engaged in providing medical services. Its medical services focus on cancer prevention, diagnosis, treatment and rehabilitation. The Company is also engaged in the research and development, manufacture and sales of medical equipment, as well as medical software development. Its medical equipment mainly include MASEP digital radiotherapy equipment, MASEP Gamma Knife and other large medical equipment. The Company distributes its products within domestic market and to overseas markets.
Qingdao Haiyingkang Investment Co., Ltd. and INKON Life Technology Co., Ltd. completed the acquisition of Shenzhen Shengzhong Investment Enterprise (Limited Partnership) from a group of shareholders.
INKON LIFE TECHNOLOGY CO., LTD. 
